Jinzhou Jixiang Molybdenum Co., Ltd.
SSE:603399.SS
8.65 (CNY) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,895.232 | 7,505.183 | 7,060.731 | 3,860.927 | 2,290.285 | 2,854.919 | 3,730.381 | 2,198.91 | 1,373.423 | 1,614.312 | 2,284.239 | 2,197.646 | 2,582.213 | 3,374.319 | 3,028.473 | 1,714.723 |
| Cost of Revenue
| 5,682.98 | 7,735.475 | 5,976.388 | 3,601.965 | 2,186.634 | 2,699.676 | 3,321.78 | 1,892.438 | 1,269.869 | 1,625.114 | 2,120.592 | 2,045.113 | 2,398.961 | 3,170.373 | 2,838.906 | 1,597.341 |
| Gross Profit
| 212.252 | -230.292 | 1,084.343 | 258.962 | 103.651 | 155.243 | 408.602 | 306.471 | 103.554 | -10.802 | 163.647 | 152.533 | 183.251 | 203.946 | 189.567 | 117.382 |
| Gross Profit Ratio
| 0.036 | -0.031 | 0.154 | 0.067 | 0.045 | 0.054 | 0.11 | 0.139 | 0.075 | -0.007 | 0.072 | 0.069 | 0.071 | 0.06 | 0.063 | 0.068 |
| Reseach & Development Expenses
| 54.127 | 49.057 | 73.248 | 1.948 | 1.549 | 1.035 | 0.772 | 1.404 | 3.855 | 7.066 | 2.131 | 1.6 | 0.695 | 0 | 0 | 0 |
| General & Administrative Expenses
| 22.793 | 32.388 | 21.418 | 15.395 | 17.66 | 25.343 | 27.742 | 23.32 | 10.56 | 16.032 | 9.121 | 6.019 | 8.233 | 8.792 | 8.076 | 6.623 |
| Selling & Marketing Expenses
| 3.334 | 5.08 | 10.251 | 6.34 | 14.258 | 21.118 | 17.013 | 13.339 | 13.593 | 9.145 | 9.097 | 8.61 | 8.879 | 10.607 | 9.694 | 7.686 |
| SG&A
| 26.127 | 37.468 | 31.669 | 21.735 | 31.918 | 46.461 | 44.755 | 36.659 | 24.153 | 25.177 | 18.218 | 14.628 | 17.112 | 19.398 | 17.77 | 14.308 |
| Other Expenses
| 68.764 | 78.449 | 151.684 | 98.634 | 80.505 | 118.552 | 234.434 | 100.051 | 18.078 | 23.275 | 36.687 | 14.874 | 7.482 | 4.481 | 9.582 | 8.926 |
| Operating Expenses
| 149.018 | 164.975 | 256.6 | 122.316 | 113.972 | 166.048 | 174.169 | 158 | 115.049 | 72.135 | 50.621 | 38.588 | 39.116 | 36.873 | 34.477 | 24.3 |
| Operating Income
| 63.234 | -395.267 | 775.432 | 146.029 | 7.573 | 10.8 | 35.052 | 146.845 | 18.258 | -496.089 | 34.821 | 58.623 | 113.13 | 117.223 | 106.236 | 72.202 |
| Operating Income Ratio
| 0.011 | -0.053 | 0.11 | 0.038 | 0.003 | 0.004 | 0.009 | 0.067 | 0.013 | -0.307 | 0.015 | 0.027 | 0.044 | 0.035 | 0.035 | 0.042 |
| Total Other Income Expenses Net
| 3.114 | -2.095 | -4.012 | -4.977 | 1.51 | -35.828 | 234.434 | 100.051 | 17.759 | 18.478 | 36.676 | 14.807 | -22.561 | -44.348 | -40.555 | -13.595 |
| Income Before Tax
| 66.348 | -397.362 | 771.421 | 37.222 | -305.579 | -224.194 | 269.485 | 246.895 | 36.331 | -477.612 | 71.497 | 73.43 | 120.609 | 121.704 | 115.744 | 80.971 |
| Income Before Tax Ratio
| 0.011 | -0.053 | 0.109 | 0.01 | -0.133 | -0.079 | 0.072 | 0.112 | 0.026 | -0.296 | 0.031 | 0.033 | 0.047 | 0.036 | 0.038 | 0.047 |
| Income Tax Expense
| 34.246 | -24.806 | 127.117 | 25.17 | -41.733 | 4.236 | 79.911 | 32.107 | 13.887 | -68.267 | 18.608 | 19.668 | 31.717 | 31.083 | 29.701 | 20.389 |
| Net Income
| 25.422 | -337.314 | 492.283 | 12.052 | -263.846 | -228.43 | 190.665 | 219.651 | 29.374 | -352.287 | 55.396 | 54.853 | 90.059 | 91.566 | 86.268 | 61.222 |
| Net Income Ratio
| 0.004 | -0.045 | 0.07 | 0.003 | -0.115 | -0.08 | 0.051 | 0.1 | 0.021 | -0.218 | 0.024 | 0.025 | 0.035 | 0.027 | 0.028 | 0.036 |
| EPS
| 0.05 | -0.65 | 0.96 | 0.024 | -0.52 | -0.42 | 0.35 | 0.42 | 0.06 | -0.87 | 0.16 | 0.16 | 0.31 | 0.34 | 0.34 | 0.36 |
| EPS Diluted
| 0.05 | -0.65 | 0.96 | 0.024 | -0.52 | -0.42 | 0.35 | 0.42 | 0.06 | -0.87 | 0.16 | 0.16 | 0.31 | 0.34 | 0.34 | 0.36 |
| EBITDA
| 199.622 | -240.123 | 899.363 | 168.617 | -189.999 | -67.927 | 411.106 | 399.274 | 57.355 | -370.63 | 168.526 | 149.84 | 145.746 | 149.594 | 140.817 | 94.477 |
| EBITDA Ratio
| 0.034 | -0.032 | 0.127 | 0.044 | -0.083 | -0.024 | 0.11 | 0.182 | 0.042 | -0.23 | 0.074 | 0.068 | 0.056 | 0.044 | 0.046 | 0.055 |